BMT-052

• Description:

  BMT-052 is a pan-genotypic hepatitis C (HCV) NS5B polymerase primer grip inhibitor[1].

• UNSPSC:

  12352005

• Target:

  HCV

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Solubility:

  10 mM in DMSO

• Smiles:

  CNC(C1=C(C2=CC=C(C=C2)F)OC3=NC(CCC(F)(F)F)=C(C4=CN=C(OC([2H])([2H])[2H])C(C(NC(C([2H])([2H])[2H])(C5=NOC=N5)C([2H])([2H])[2H])=O)=C4)C=C13)=O

• Molecular Formula:

  C30H17D9F4N6O5

• Molecular Weight:

  635.61

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported

• CAS Number:

  [1628720-84-2]